Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESMO 2019 | Improving patient selection for surgical candidates with head and neck cancer

Hisham Mehanna • 28 Sep 2019
ESMO 2019
Head and Neck Cancer

Hisham Mehanna, PhD, BMedSc, MBChB, FRCS, FRCS(ORL-HNS), University of Birmingham, Birmingham, UK, discusses improving patient selection for surgical candidates with head and neck cancer. This interview took place at the European Society for Medical Oncology (ESMO) 2019 congress in Barcelona, Spain.

More from Hisham Mehanna

3:58
Updates on HPV+ oropharyngeal cancer - de-escalation and reducing costs with cisplatin
Hisham Mehanna • 30 Sep 2019
2:31
Changes in the staging system for HPV+ cancer patients
Hisham Mehanna • 29 Nov 2018
2:12
The omega score: an emerging biomarker for risk determination
Hisham Mehanna • 29 Nov 2018
1:23
Evaluating options for HPV+ oropharyngeal cancer: cisplatin-RT vs. cetuximab-RT
Hisham Mehanna • 29 Nov 2018

Related Videos

1:03
Challenges in implementing liquid biopsies for head and neck cancer
Mouadh Barbirou • 7 Apr 2024
2:43
Molecular profiling of tumor biomarkers in head and neck cancer
Mouadh Barbirou • 7 Apr 2024
1:40
The future of squamous cell carcinoma research at ESMO Asia 2023
Brian Henick • 6 Dec 2023
0:54
The role of immunotherapy in PD-L1 low advanced squamous cell carcinoma
Brian Henick • 6 Dec 2023
The content of VJOncology is intended for healthcare professionals